Table 4.
The prescribing pattern of antipsychotics among patients with schizophrenia in Africa
| Antipsychotic therapy class | Oral FGA mono | Oral SGA monotherapy | IM FGA monotherapy | IM SGA monotherapy | Comb PO FGAs | PO FGAs +PO SGAs | IM FGAs +PO FGAs | IM FGAs + PO SGAs | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Author and year | Monotherapy | Polypharmacy | ||||||||
| Amr et al., 2012 | 32 (37.6%) | 53 (62.4%) | 45 (52.9%) | 20 (23.5%) | 20 (23.5%) | 32 (0.71%) | 4 (4.7%) | 12 (14.1%) | 11 (12.9%) | 0% |
| Olotu et al., 2017 | 74 (29.6%) | 176 (70.4%) | 37 (15.2%) | 34 (13.6%) | 3 (1.2%) | 30 (12.0%) | 1 (0.4%) | 111 (44.0%) | 34 (14.0%) | |
| Anozie, et al., 2020 | 157 (49.06%) | 163 (50.94%) | 218 (68.2%) | 110 (34.4%) | 168 (52.5%) | 0% | 2 (1.2%) | 1 (0.6%) | 72 (44.3%) | 75 (46.0%) |
| Armstrong and Temmingh, 2017 | 413 (71.57%) | 164 (28.43%) | 189 (46.0%) | 196 (47.0%) | 25 (5.93%) | 3 (0.7%) | 0% | 1 (0.6%) | 74 (4.9%) | 68 (41.0%) |
| Koen, 2008 | 364 (71.37%) | 146 (28.63%) | 298 (58.5%) | 40 (78.4%) | 252 (49.4%) | 0% | 65 (45.77%) | 0% | 77 (54.2%) | 11 (22.0%) |
FGA, first generation antipsychotic; IM, intra muscular ; SGA, second generation antipsychotic; PO, oral.